Search

Your search keyword '"Weger, Roman"' showing total 27 results

Search Constraints

Start Over You searched for: Author "Weger, Roman" Remove constraint Author: "Weger, Roman"
27 results on '"Weger, Roman"'

Search Results

1. Using the Computer-based Health Evaluation System (CHES) to Support Self-management of Symptoms and Functional Health: Evaluation of Hematological Patient Use of a Web-Based Patient Portal

2. Prevalence and outcome of coronary artery disease in cardiac amyloidosis: A retrospective Austrian multicenter study

5. P-487 Adherence to patient-reported symptom monitoring and subsequent clinical interventions for patients with multiple myeloma in outpatient care: a longitudinal observational study

6. Adherence to Patient-Reported Symptom Monitoring and Subsequent Clinical Interventions for Patients With Multiple Myeloma in Outpatient Care: Longitudinal Observational Study

7. Attrition Rates in Multiple Myeloma Treatment under Real World Conditions—An Analysis from the Austrian Myeloma Registry (AMR)

8. Adherence to patient-reported symptom monitoring and subsequent clinical interventions for patients with Multiple Myeloma in outpatient care: a longitudinal observational study (Preprint)

9. Ninreal - a Real World (RW) Comparison of Ixazomib Triplets and IMiD Duplets, in Relapsed and Refractory Multiple Myeloma (RRMM) from the Austrian Myeloma Registry (AMR)

12. The cancer patient’s perspective of COVID‐19‐induced distress—A cross‐sectional study and a longitudinal comparison of HRQOL assessed before and during the pandemic

13. Using the Computer-based Health Evaluation System (CHES) to Support Self-management of Symptoms and Functional Health: Evaluation of Hematological Patient Use of a Web-Based Patient Portal (Preprint)

14. The prognostic value of additional copies of 1q21 in multiple myeloma depends on the primary genetic event

15. Patients with double/triple copy number gains on C-MYC, BCL2, and/or BCL6 treated with standard chemotherapy have a similarly poor prognosis than those with high-grade B cell lymphoma with C-MYC and BCL2 and/or BCL6 rearrangements: a single-center experience on a consecutive cohort of large B cell lymphomas

16. Complementing clinical cancer registry data with patient reported outcomes: A feasibility study on routine electronic patient‐reported outcome assessment for the Austrian Myelome Registry

17. Effectiveness of treatment sequences for elderly patients with multiple myeloma - a comparison of treatment schedules from clinical trials and experience from the Austrian Myeloma Registry

19. Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study

23. Low Beclin-1 expression predicts improved overall survival in patients treated with immunomodulatory drugs for multiple myeloma and identifies autophagy inhibition as a promising potentially druggable new therapeutic target: an analysis from The Austrian Myeloma Registry (AMR)

25. Bone marrow micro-environmental CD4+ and CD8+ lymphocyte infiltration patterns significantly define overall- and progression free survival in standard risk multiple myeloma: An analysis from the Austrian Myeloma Registry (AMR).

26. Bone marrow microenvironmental CD4 + and CD8 + lymphocyte infiltration patterns define overall- and progression free survival in standard risk multiple myeloma – an analysis from the Austrian Myeloma Registry.

27. Real-World Use of 3rd Line Therapy for Multiple Myeloma in Austria: An Austrian Myeloma Registry (AMR) Analysis of the Therapeutic Landscape and Clinical Outcomes prior to the Use of Next Generation Myeloma Therapeutics.

Catalog

Books, media, physical & digital resources